Journal
GUT AND LIVER
Volume 15, Issue 1, Pages 19-30Publisher
EDITORIAL OFFICE GUT & LIVER
DOI: 10.5009/gnl19265
Keywords
Liver transplant; Hepatocellular carcinoma; Surgical indication
Categories
Ask authors/readers for more resources
Liver transplant has evolved from a procedure with high mortality to a routine procedure with good survival outcomes, especially with the development of living donor liver transplant. The scope of indications for liver transplant has expanded to include various types of liver cancers and even multiple organ failure, with increasing use in elderly patients. Further development of noninvasive predictors is needed to improve patient management and outcomes.
During the past few decades, liver transplant has developed from a high-mortality procedure to an almost routine procedure with good survival outcomes. The development of living donor liver transplant has increased the availability of liver grafts, and the scope of indications for liver transplant has been expanding ever since. The aim of this review is to provide an overview of such an expansion of scope. Various criteria have been proposed to expand the eligibility of patients with hepatocellular carcinoma exceeding the Milan criteria for liver transplant. Furthermore, liver transplant is increasingly performed as a treatment modality for cholangiocarcinoma, neuroendocrine liver metastasis and colorectal liver metastasis. The number of elderly patients receiving liver transplant is on the rise. Combined organ transplantation has also been adopted to treat patients with multiple organ failure. Going forward, further development of preoperative noninvasive predictors in tumor, patient and even donor factors is needed to identify patients at risk of poor outcomes and hence optimize patient management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available